Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Davidson

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
JAMA Dermatology|September 23, 2020
Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical TrialsLawrence F Eichenfield, Wendy McFalda, Bradford Brabec, et al.
American Journal of Clinical Dermatology|February 18, 2021
Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum ContagiosumLawrence F Eichenfield, Elaine Siegfried, Pearl Kwong, et al.
Journal of Clinical Pharmacology|April 28, 2025
First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Complement Factor D Inhibitor BCX9930 in Healthy ParticipantsMatthew Davidson, Xilin Chen, Amanda Mathis, et al.
Computers in Biology and Medicine|August 23, 2021
Automatic segmentation of corneal deposits from corneal stromal dystrophy images via deep learningMihir Deshmukh, Yu-Chi Liu, Tyler Hyungtaek Rim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 6, 2020
Antibodies to gp210 and understanding risk in patients with primary biliary cholangitisDebashis Haldar, Ashnila Janmohamed, Tim Plant, et al.
Scientific Reports|August 9, 2023
Refuting the sensational claim of a Hopewell-ending cosmic airburstKevin C Nolan, Andrew Weiland, Bradley T Lepper, et al.
Psychiatry Research|March 31, 2007
Assessment and prevention of head motion during imaging of patients with attention deficit hyperactivity disorderJeffery N Epstein, B J Casey, Simon T Tonev, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2026
A fully synthetic Golden Gate assembly system for engineering a <i>Pseudomonas aeruginosa</i> phiKMV-like phageAndrew P Sikkema, Kaitlyn E Kortright, Hemaa Selvakumar, et al.
The Journal of Clinical Investigation|June 14, 2016
RAC1 activation drives pathologic interactions between the epidermis and immune cellsMårten C G Winge, Bungo Ohyama, Clara N Dey, et al.
Nature Communications|July 1, 2018
Harnessing synthetic lethality to predict the response to cancer treatmentJoo Sang Lee, Avinash Das, Livnat Jerby-Arnon, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
JAMA Dermatology|September 23, 2020
Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical TrialsLawrence F Eichenfield, Wendy McFalda, Bradford Brabec, et al.
American Journal of Clinical Dermatology|February 18, 2021
Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum ContagiosumLawrence F Eichenfield, Elaine Siegfried, Pearl Kwong, et al.
Journal of Clinical Pharmacology|April 28, 2025
First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Complement Factor D Inhibitor BCX9930 in Healthy ParticipantsMatthew Davidson, Xilin Chen, Amanda Mathis, et al.
Computers in Biology and Medicine|August 23, 2021
Automatic segmentation of corneal deposits from corneal stromal dystrophy images via deep learningMihir Deshmukh, Yu-Chi Liu, Tyler Hyungtaek Rim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 6, 2020
Antibodies to gp210 and understanding risk in patients with primary biliary cholangitisDebashis Haldar, Ashnila Janmohamed, Tim Plant, et al.
Scientific Reports|August 9, 2023
Refuting the sensational claim of a Hopewell-ending cosmic airburstKevin C Nolan, Andrew Weiland, Bradley T Lepper, et al.
Psychiatry Research|March 31, 2007
Assessment and prevention of head motion during imaging of patients with attention deficit hyperactivity disorderJeffery N Epstein, B J Casey, Simon T Tonev, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2026
A fully synthetic Golden Gate assembly system for engineering a <i>Pseudomonas aeruginosa</i> phiKMV-like phageAndrew P Sikkema, Kaitlyn E Kortright, Hemaa Selvakumar, et al.
The Journal of Clinical Investigation|June 14, 2016
RAC1 activation drives pathologic interactions between the epidermis and immune cellsMårten C G Winge, Bungo Ohyama, Clara N Dey, et al.
Nature Communications|July 1, 2018
Harnessing synthetic lethality to predict the response to cancer treatmentJoo Sang Lee, Avinash Das, Livnat Jerby-Arnon, et al.
Pageof 4